Stocks · Health care · Pharmaceutical Preparations

MANNKIND CORP

MNKD Clue Score45
United States Fiscal year ends December CIK 0000899460 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Michael Castagna
17 Dec 2025
Chief Executive Officer
Sold after exercise
65,804
$6.01
$395.48K
Michael Castagna
16 Dec 2025
Chief Executive Officer
Sold after exercise
21,310
$6.00
$127.86K
Michael Castagna
12 Dec 2025
Chief Executive Officer
Sold after exercise
20,806
$6.00
$124.84K
David Thomson
2 Dec 2025
EVP Genl Counsel & Secretary
Sold after exercise
147,780
$5.57
$823.13K
Michael Castagna
2 Dec 2025
Chief Executive Officer
Sold after exercise
107,920
$5.57
$601.11K
Steven B. Binder
22 Nov 2024
Director
Sold after exercise
67,536
$6.89
$465.32K
Steven B. Binder
15 Nov 2024
Director
Sold after exercise
67,539
$6.76
$456.56K

What was left out

Form 4 filings counted 390
Amendments (4/A) skipped 32
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 36
Sales straight out of an exercise 7
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 20,580,059
Sales filed before the plan box existed 6
History held since 17 Oct 2006